Futibatinib, a drug developed by Taiho Oncology in Japan, has been approved in the United States, Japan, and the European Union. Its appearance provides a new treatment for patients with bile duct diseases. So, what are the instructions, medical insurance, price, efficacy, and side effects of futibatinib (LYTGOBI)?

Futibatinib (LYTGOBI) instructions, medical insurance, price, efficacy, side effects

Futibatinib was developed by Taiho Oncology in Japan. The following will introduce the instructions, medical insurance, price, efficacy, and side effects of futibatinib:

Instructions

Futibatinib is a second-generation FGFR targeted drug, mainly used to treat patients with bile duct diseases who are resistant to treatment with first-generation FGFR inhibitors. The recommended dose is 20mg per day, taken orally once a day, with or without food, and swallowed whole. Futibatinib should be stored at room temperature of 20-25°C. The validity period is 24 months.

Medical insurance

Futibatinib has not yet been launched in China and has not been included in China's medical insurance system. Patients need to purchase the drug at their own expense.

Price

The generic version of Futibatinib produced by Lucius in Laos is 4mg*35 tablets.

Futibatinib is an effective targeted drug for bile duct diseases. During use, it is necessary to pay attention to its side effects and medication precautions. Patients should follow the doctor's instructions when using the drug and pay close attention to the body's reactions. If you have any questions or discomfort, you should seek medical attention in time and consult a professional doctor.

Futibatinib (LYTGOBI) efficacy, side effects

Futibatinib is a targeted drug for bile duct diseases and belongs to the second-generation FGFR inhibitor. The following is a detailed introduction to its efficacy and side effects:

Efficacy

As a second-generation FGFR targeted drug, Futibatinib may have a good effect in treating patients with bile duct diseases who are resistant to first-generation FGFR inhibitors.

Side effects

Futibatinib may cause some side effects, including but not limited to ocular toxicity (such as retinal pigment epithelial detachment, which may cause blurred vision and other symptoms) and hyperphosphatemia (which may cause soft tissue mineralization, calcification, etc.). During use, the patient's reaction should be closely monitored and appropriate treatment measures should be taken as needed.

Futibatinib may also cause other adverse reactions. When using Futibatinib, patients should follow the doctor's instructions and suggestions, pay close attention to their physical reactions, and report any discomfort symptoms to the doctor in a timely manner.